SNES
SenesTech, Inc.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$1.00
−3.85%Year over year
Reported trailing growth
- Revenue
- +13.4%
- EBITDA
- -16.8%
- EBIT
- -18.5%
- EPS
- +78.2%
- Free cash flow
- -23.7%
- Operating cash flow
- -25.6%
Forward estimates
Based on analyst estimates
- Revenue
- -29.9%
- EBITDA
- +51.5%
- EPS
- +53.2%
Three-year CAGR
- Revenue
- +29.7%
- EBITDA
- -3.7%
- EBIT
- -4.1%
- Net income
- -3.2%
- EPS
- +78.0%
- Free cash flow
- +3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026